Prolactin, a natriuretic hormone, interacting with the renal dopamine system

Kidney International

Volumn 68, Issue 4, 2005, Pages 1700-1707

  Ibarra, Fernando ^b   Crambert, Susanne ^b   Eklöf, Ann Christine ^b   Lundquist, Annika ^b   Hansell, Peter ^b   Holtbäck, Ulla ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

ATPase; Dopamine; K+ ; Kidney; Na+; Prolactin; Urinary sodium excretion

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM); ADENOSINE TRIPHOSPHATE; AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; NATRIURETIC FACTOR; OUABAIN; POTASSIUM ION; PROLACTIN; SODIUM ION; WATER;

ANESTHESIA; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIURESIS; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GLOMERULUS FILTRATION RATE; HORMONAL REGULATION; HORMONE ACTION; IN VITRO STUDY; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; MALE; MEAN ARTERIAL PRESSURE; MICRODISSECTION; NONHUMAN; POTASSIUM EXCRETION; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; RAT; RAT STRAIN; SODIUM EXCRETION; SODIUM URINE LEVEL;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; DOPAMINE; DOPAMINE ANTAGONISTS; KIDNEY TUBULES, PROXIMAL; MALE; NA(+)-K(+)-EXCHANGING ATPASE; NATRIURESIS; PROLACTIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; WATER-ELECTROLYTE BALANCE;

EID: 31644434620     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00586.x     Document Type: Article

References (35)

1. FREEMAN ME, KANYICSKA B, LERANT A, NAGY G: Prolactin: Structure, function, and regulation of secretion. Physiolog Rev 80:1523-1631, 2000
2. PICKFORD GE, PHILLIPS JG: Prolactin, a factor in promoting survival of hypophysectomized killifish in fresh water. Science 130:454-455, 1959
3. 3H]ouabain binding of lactating rabbit mammary tissue. J Physiol (Lond) 334:1-17, 1983
4. FALCONER IR, ROWE JM: Possible mechanism for action of prolactin on mammary cell sodium transport. Nature 256:327-328, 1975
5. MANKU MS, MTABAJI JB, HORROBIN DF: Effect of cortisol, prolactin and ADH on the amniotic membrane. Nature 258:78-80, 1975
6. RAMSEY DH, BERN HA: Stimulation by ovine prolactin of fluid transfer in everted sacs of rat small intestine. J Endocrinol 53:453-459, 1972
7. ALDER RA, HERZBERG VL, BRINCK-JOHNSEN T, SOKOL W: Increased water excretion in hyperprolactinemic rats. Endocrinology 118:1519-1522, 1986
8. ROBERTS JR: The effect of acute or chronic administration of prolactin on renal function in fetal chickens. J Comp Physiol [B] 168:25-31, 1998
9. MORRISSEY SE, NEWTH T, REES R, et al: Renal effects of recombinant prolactin in anaesthetized rats. Eur J Endocrinol 145:65-71, 2001
10. LUCCI MS, BENGELE HH, SOLOMON S: Suppressive action of prolactin on renal response to volume expansion. Am J Physiol 229:81-85, 1975
11. MILLS DE, BUCKMAN MT, PEAKE GT: Mineralocorticoid modulation of prolactin effect on renal solute excretion in the rat. Endocrinology 112:823-828, 1983
12. STIER CT, COWDEN EA, JR., FRIESEN HG, ALLISON MEM: Prolactin and the rat kidney: A clearance and micropuncture study. Endocrinology 115:362-367, 1984
13. BOLE-FEYSOT C, GOFFIN V, EDERY M, et al: Prolactin (PRL) and its receptor: Actions, signal transduction, and phenotypes observed in PRL receptor knockout mice. Endocrine Rev 19:225-268, 1998
14. MOUNTJOY K, COWDEN EA, DOBBIE JW, RATCLIFFE JG: Prolactin receptors in the rat kidney. J Endocrinol 87:47-54, 1980
15. DICKLEY RP, STONE SC: Drugs that affect the breast and lactation. Clin Obstet Gynecol 18:95-111, 1975
16. BEN-JONATHAN N, HNASKO R: Dopamine as a prolactin (PRL) inhibitor. Endocrine Rev 22:724-763, 2001
17. BRIDGES RS, RONSHEIM PM: Prolactin (PRL) regulation of maternal behavior in rats: Bromocriptin treatment delays and PRL promotes the rapid onset of behavior. Endocrinology 126:837-848, 1990
18. APERIA A: Intrarenal dopamine: A key signal in the interacticve regulation of sodium metabolism. Ann Rev Physiol 62:621-647, 2000
19. HOLTBÄCK U, KRUSE MS, BRISMAR H, APERIA A: Intrarenal dopamine coordinates the effect of antinatriuretic and natriuretic factors. Acta Physiol Scand 168:215-218, 2000
20. BRISMAR H, AGRÉN M, HOLTBÄCK U: β-adrenoceptor agonist sensitizes the dopamine D1 receptor in renal tubular cells. Acta Physiol Scand 175:333-340, 2002
21. SOARES-DA-SILVA O, SERRAO MP, VIEIRA-COELHO MA: Apical and basolateral uptake and intracellular fate of dopamine precursor L-dopa in LLC-PK1 cells. Am J Physiol 274:F243-F251, 1998
22. GRENADER A, HEALY DP: Locally formed dopamine stimulates cAMP accumulation in LLC-PK1 cells via a DA1 dopamine receptor. Am J Physiol 260:F906-F912, 1991
23. SELVARAJ NG, OMI E, GIBORI G, RAO MC: Janus kinase 2 (JAK2) regulates prolactin-mediated chloride transport in mouse mammary epithelial cells through tyrosine phosphorylation of Na, K, 2Cl co-transporter. Molecular Endocrin 14:2054-2065, 2000
24. HOLTBÄCK U, BRISMAR H, DI BONA GF, et al: Receptor recruitment: A mechanism for interaction between G protein-coupled receptors. Proc Natl Acad Sci USA 96:7271-7275, 1999
25. EDWARDS RM, BROOKS DP. Dopamine inhibits vasopressin action in the rat inner medullary collecting duct via alpha(2)-adrenoceptors. J Pharmacol Exp Ther 298:1001-1006, 2001
26. EKLÖF A-C, HOLTBÄCK U, SUNDELÖF M, et al: Inhibition of COMT induces dopamine-dependent natriuresis and inhibition of proximal tubular Na, K-ATPase activity. Kidney Int 52:742-747, 1997
27. HANSELL P, FASCHING A: The effect of dopamine receptor blockade on natriuresis is dependent on the degree of hypervolemia. Kidney Int 39:253-258, 1991
28. ALI S, PELLEGRINI I, KELLY PA: A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor. J Biol Chem 266:20110-20117, 1991
29. HARDMAN JE, LIMBIRD LE, GILMAN AG: Hormones and hormone antagonists, prolactin, in Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10th ed., New York, McGraw-Hill, 2001, pp 1549-1551
30. RANG HP, DALE MM, RITTER JM: The central nervous system, in Pharmacology, 4th ed., Edinburgh, Churchill Livingstone, 1999, pp 483-542 (464-647)
31. HANSELL P, ULFENDAHL HR: Effects of atrial natriuretic peptide (ANP) during converting enzyme inhibition. Acta Physiol Scand 130: 393-399, 1987
32. APERIA A, BERTORELLO A, SERI I: Dopamine causes inhibition of Na, K-ATPase activity in proximal tubular segments. Am J Physiol 252:F39-F45, 1987
33. FELDER CC, CAMPBELL T, ALBRECHT F, JOSE PA: Dopamine inhibits Na, H-exchanger activity in renal BBMV by stimulation of adenylate cyclase. Am J Physiol 259:F297-F303, 1990
34. HANSELL P, FASCHING A, SJÖQUIST M, et al: The dopamine receptor antagonist haloperidol blocks natriuretic but not hypotensive effects of the atrial natriuretic factor. Acta Physiol Scand130:401-407, 1987
35. COSTA MDE L, LORIA A, MARCHETTI M, et al: Effects of dopamine and nitric oxide on arterial pressure and renal function in volume expansion. Clin Exp Pharmacol Physiol 29:772-776, 2002